Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

New Mesothelioma Drug Treatment Showing Promise

Plos One, an online publication that offers access to peer-reviewed scientific information, recently released some promising results from a study conducted in Stockholm, Sweden, looking into the effectiveness of a variety of mesothelioma medications. The study looked at a total of six different medications, some of which have long been in use while others have only recently been introduced in mesothelioma treatment. The drugs were tested on different types of mesothelioma cell lines and were applied by themselves as well as in a variety of combinations to test their effectiveness in killing the dangerous mesothelioma cancer cells.

Among the medications being tested were four that are familiar to many who follow mesothelioma research – these include pemetrexed, carboplatin, gemcitabine, and doxorubicin, all of which have been found helpful in specific applications for mesothelioma treatment. The two new medications were selenite, which is derived from selenium, and a proteasome inhibitor called bortezomib.

The tests showed that selenite proved to have the greatest effect, impacting four out of six of the mesothelioma cell lines, and was even more effective when combined with the other new drug, bortezomib. The reason that researchers are looking into treating mesothelioma with combinations of drugs rather than with single applications of a medication is that there are actually three different types of mesothelioma cells – epithelial, sarcomatoid, and mixed – and each of these types of cells respond differently to different medications. Also important to remember is that a single patient can exhibit all three types of cell at the same time.

Mesothelioma is a fatal and rare form of cancer that is caused by exposure to asbestos. The disease is only diagnosed in approximately 3,500 patients each year, with the average life expectancy for a mesothelioma patient from time of diagnosis being about two years. One of the reasons that mesothelioma patients have such a short survival time is that the disease doesn’t make itself known until many years after it has started to grow in the body, and by the time that it is diagnosed it has often spread beyond the point where surgery can be effective.

According to Plos One, the search for new and effective medicines for the treatment of mesothelioma has highlighted the many different ways that the disease can manifest itself from patient to patient. Understanding the ways that medications can work together against a specific type of cell or tumor will aid in physicians’ ability to treat each individual most effectively.

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor and proofreader. She graduated from the College of William and Mary with a degree in English. Her dreams of a writing career were diverted by a need to pay her bills. She spent a few years providing copy for a major retailer, then landed a lucrative career in advertising sales. With college bills for all three of her kids paid, she left corporate America for a return to her original goal of writing. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.

Get Your FREE Resources Sent Overnight

  • New treatment options
  • Veterans benefits & claims
  • $30 Billion asbestos trust fund information

– Or Call –

Site Navigation

Where can I

Get Additional Help?

For over 15 years, we’ve provided the best FREE resources to mesothelioma patients and loved ones. Our resources include information on the leading treatment options and best doctors in your area; lessons learned from survivors; claims and benefits specifically for Veterans; and how to access your share of billions of dollars in trust fund money.

Get Your FREE Resources Sent Overnight

  • New Treatment Options
  • Veteran's Benefits & Claims
  • $30 Billion Asbestos Trust Fund Information

– Or Call –

We are here to help you


If you've been diagnosed with asbestos-related cancer, contact us at 1-800-692-8608 to find out if you are eligible to receive compensation. You can also fill out the form above to receive FREE information.

Quick Compensation - $30 Billion Trusts
$30 Billion Asbestos Trusts
Get Started